Background Amyotrophic lateral sclerosis (ALS) is a progressive and often fatal neurodegenerative disease characterized by the loss of Motor Neurons (MNs) in spinal cord, motor cortex and brainstem. Despite significant efforts in the field, the exact pathogenetic mechanisms underlying both familial and sporadic forms of ALS have not been fully elucidated, and the therapeutic possibilities are still very limited. Here we investigate the molecular mechanisms of neurodegeneration induced by chronic exposure to the environmental cyanotoxin L-BMAA, which causes a form of ALS/Parkinson’s disease (PD) in several populations consuming food and/or water containing high amounts of this compound. Methods In this effort, mice were chronically exposed to L-BMAA and analyzed at different time points to evaluate cellular and molecular alterations and behavioral deficits, performing MTT assay, immunoblot, immunofluorescence and immunohistochemistry analysis, and behavioral tests. Results We found that cyanotoxin L-BMAA determines apoptotic cell death and a marked astrogliosis in spinal cord and motor cortex, and induces neurotoxicity by favoring TDP-43 cytoplasmic accumulation. Conclusions Overall, our results characterize a new versatile neurotoxic animal model of ALS that may be useful for the identification of new druggable targets to develop innovative therapeutic strategies for this disease.

Chronic exposure to l-BMAA cyanotoxin induces cytoplasmic TDP-43 accumulation and glial activation, reproducing an amyotrophic lateral sclerosis-like phenotype in mice / Anzilotti, Serenella; Valente, Valeria; Brancaccio, Paola; Franco, Cristina; Casamassa, Antonella; Lombardi, Giovanna; Palazzi, Alessandra; Conte, Andrea; Paladino, Simona; Canzoniero, Lorella Maria Teresa; Annunziato, Lucio; Pierantoni, Giovanna Maria; Pignataro, Giuseppe. - In: BIOMEDICINE & PHARMACOTHERAPY. - ISSN 1950-6007. - 167:(2023), p. 115503. [10.1016/j.biopha.2023.115503]

Chronic exposure to l-BMAA cyanotoxin induces cytoplasmic TDP-43 accumulation and glial activation, reproducing an amyotrophic lateral sclerosis-like phenotype in mice

Anzilotti, Serenella;Valente, Valeria;Brancaccio, Paola;Franco, Cristina;Casamassa, Antonella;Palazzi, Alessandra;Conte, Andrea;Paladino, Simona;Annunziato, Lucio;Pierantoni, Giovanna Maria
;
Pignataro, Giuseppe
2023

Abstract

Background Amyotrophic lateral sclerosis (ALS) is a progressive and often fatal neurodegenerative disease characterized by the loss of Motor Neurons (MNs) in spinal cord, motor cortex and brainstem. Despite significant efforts in the field, the exact pathogenetic mechanisms underlying both familial and sporadic forms of ALS have not been fully elucidated, and the therapeutic possibilities are still very limited. Here we investigate the molecular mechanisms of neurodegeneration induced by chronic exposure to the environmental cyanotoxin L-BMAA, which causes a form of ALS/Parkinson’s disease (PD) in several populations consuming food and/or water containing high amounts of this compound. Methods In this effort, mice were chronically exposed to L-BMAA and analyzed at different time points to evaluate cellular and molecular alterations and behavioral deficits, performing MTT assay, immunoblot, immunofluorescence and immunohistochemistry analysis, and behavioral tests. Results We found that cyanotoxin L-BMAA determines apoptotic cell death and a marked astrogliosis in spinal cord and motor cortex, and induces neurotoxicity by favoring TDP-43 cytoplasmic accumulation. Conclusions Overall, our results characterize a new versatile neurotoxic animal model of ALS that may be useful for the identification of new druggable targets to develop innovative therapeutic strategies for this disease.
2023
Chronic exposure to l-BMAA cyanotoxin induces cytoplasmic TDP-43 accumulation and glial activation, reproducing an amyotrophic lateral sclerosis-like phenotype in mice / Anzilotti, Serenella; Valente, Valeria; Brancaccio, Paola; Franco, Cristina; Casamassa, Antonella; Lombardi, Giovanna; Palazzi, Alessandra; Conte, Andrea; Paladino, Simona; Canzoniero, Lorella Maria Teresa; Annunziato, Lucio; Pierantoni, Giovanna Maria; Pignataro, Giuseppe. - In: BIOMEDICINE & PHARMACOTHERAPY. - ISSN 1950-6007. - 167:(2023), p. 115503. [10.1016/j.biopha.2023.115503]
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S075333222301301X-main.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Dominio pubblico
Dimensione 7.27 MB
Formato Adobe PDF
7.27 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/939248
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact